Home
Glaxosmithkline Pharmaceuticals Ltd Share Price History

Glaxosmithkline Pharmaceuticals Ltd
NSE : 09 Apr, 2025
2675.3-53.1 (-1.9%)
Prev Close
2728.4
Open Price
2701.1
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
133036
Today's High / Low
2710.0 / 2640.1
52 WK High / Low
3088.0 / 1842.1
Market Price of Glaxosmithkline Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
Date | Price | Open | High | Low |
---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
Parameter | |
---|---|
Sales (Cr.) | NaN |
Sales YoY Gr. | - |
Adj EPS | 39.76 |
YoY Gr. | - |
Net Profit (Cr.) | 337 |
BVPS | 236.93 |
Key Financial Parameters
Parameter | |
---|---|
Return on Capital Emp. % | 27.81 |
Op. Profit Mgn % | 22.91 |
Net Profit Mgn % | 13.97 |
Debt to Equity % | 0 |
Latest Shareholding
Promoters Holdings Over Time
About Glaxosmithkline Pharmaceuticals Ltd
- GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together.
- The Company is headquartered in Mumbai and it has six branch offices, a manufacturing facility at Nashik in Maharashtra, 22 contract manufacturing organisations (CMOs) with regional and sales hubs across India.
- The Company is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals. The Company's portfolio includes General Medicines, Vaccines and Specialty medicines that help prevent and treat disease.
- Their prescription medicines range across therapeutic areas, such as Anti-Infectives, Dermatology, Gynaecology, Diabetes, Oncology, Cardiovascular Disease and Respiratory Diseases.
Popular Search
FAQs for Glaxosmithkline Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Glaxosmithkline Pharmaceuticals Ltd's share price history?
Key events that impact Glaxosmithkline Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Glaxosmithkline Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Glaxosmithkline Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Glaxosmithkline Pharmaceuticals Ltd?
Dividends can influence Glaxosmithkline Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Glaxosmithkline Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Glaxosmithkline Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Glaxosmithkline Pharmaceuticals Ltd’s share price history?
To understand Glaxosmithkline Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.